Managing Opioid Misuse Disorder in Pregnancy and Neonatal Care is organized by Virtual Lecture Hall (VLH).
Current CME Approval Period: October 20, 2021 - October 19, 2024
Original Release Date: October 20, 2017
Accreditation: 1.00 AMA PRA Category 1 Credit(s)TM
This course familiarizes physicians with evaluation and treatment of patients who present with maternal opioid use during and after pregnancy.
As a result of completing this activity, the participant will be better able to:
• Identify the specific problems encountered by women using opioids during pregnancy
• Evaluate pregnant patients with a history of maternal opioid use
• Differentiate between maintenance options for opioid treatment during pregnancy
• Assess when it is appropriate for a pregnant patient to undergo medically-supervised withdrawal from heroin.
• Educate patients with opioid dependence who are considering pregnancy so that they can be referred for appropriate services
• Determine the initial post-delivery treatment plan for an infant exposed to maternal methadone during pregnancy
• Educate patients on appropriate ways of feeding an infant at risk of opioid withdrawal
• Appropriately assess at-risk infants by describing the symptoms of neonatal opioid withdrawal
• Determine appropriate discharge expectations for an at-risk infant not needing pharmacologic treatment for withdrawal
Additional details will be posted as soon as information is available.